Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
infants
100%
antibodies
79%
tetanus
63%
reviews
49%
immunity
43%
vaccines
40%
doxorubicin
31%
cyclophosphamide
31%
prednisone
31%
chemotherapy
31%
diphtheria
31%
kinetics
31%
assessments
31%
toxoids
31%
adults
31%
plasma cells
30%
pregnancy
28%
strains
17%
inflammation
17%
diseases
17%
levels
16%
comparative evaluations
15%
concentration
14%
fluctuations
12%
birth
12%
women
12%
complement
11%
protection
11%
data
8%
control
7%
Keyphrases
Immunization
39%
B Cells
39%
Doxorubicin
31%
B-cell Depletion
31%
Chemotherapy
31%
B-cell Immune Response
31%
Bordetella Pertussis
31%
Immunomodulating
31%
Rituximab
31%
Intrauterine Exposure
31%
R-CHOP
31%
Prednisone
31%
Cyclophosphamide
31%
Maternal Tetanus
31%
Tetanus-diphtheria-acellular Pertussis
31%
Immunosuppressive Medication
31%
Pertussis Vaccination
31%
Tdap
31%
During Pregnancy
27%
Inflammatory Bowel Disease
27%
Immunization Strategy
15%
Natural Infection
15%
Response to Infection
15%
Pertussis
15%
Exposed Infants
15%
Immune System
15%
Mother-infant Pairs
15%
Mean Concentration
15%
Fragment C
9%
First Year of Life
7%
Immunology and Microbiology
B Cell
63%
Immune System
55%
Rituximab
31%
Prednisone
31%
Bordetella Pertussis
31%
Immune Response
31%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
31%
Cyclophosphamide
31%
Inflammatory Bowel Disease
31%
DPT Vaccine
31%
Immaturity
31%
Infectious Disease
21%
Infection
21%
Pertussis Vaccine
15%
Immunogenicity
10%
Morbidity
10%
Immunocompetent Cell
10%
Maturation
10%
Adaptive Immune System
10%
Pathogen Clearance
10%
Pertactin
9%
Lymphocytopenia
7%
CD20
7%
Placenta
7%
Hypogammaglobulinemia
7%
Mucosa
7%
Whole Cell
7%
Pertussis Toxin
7%
Natural Killer Cell
7%
Immunoglobulin A
7%